HOUSTON, 2 JULY 2024: An Indian national is set to appear for his detention hearing on charges related to his alleged sale and shipment of counterfeit cancer pharmaceuticals into the United States, announced U.S. Attorney Alamdar S. Hamdani.

 

Authorities arr......
View Details

Related News

• Telangana DCA busted a unit manufacturing spurious 'Eptoin' and 'Vasograin Tab' (04-07-2024)

---

• Ministry of Ayush notifies omission of Rule 170 that regulate ads of ASU drugs (04-07-2024)

---

• USFDA issued warning letter to Sun Pharma for manufacturing issues at Dadra facility (04-07-2024)

---

• Punjab-based company booked for producing ‘substandard’ antibiotic (04-07-2024)

---

• 60 small drug makers join govt scheme to modernise pharma manufacturing units (04-07-2024)

---

• Centre eases rules for global sourcing of 354 medical devices (03-07-2024)

---

• Lilly received marketing authorization for Tirzepatide in India (03-07-2024)

---

• Delhi HC quashes PCI's decision on annual approval for pharmacy courses (03-07-2024)

---

• DoP to launch scheme for common facilities in state-supported medical device parks: DoP Secretary (03-07-2024)

---

• Multiple Pharmaceutical Firms Under Scrutiny For Illicit Drug Manufacturing & Distribution: ED Probe (03-07-2024)

---